ENTX vs REG · rev $181.0K vs P/E 34, $12.93B cap
Entera Bio Ltd (ENTX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ENTX revenue for 2024-12-31 was $181.0K. Net income was -$9.5M. ENTX currently screens at market cap $58.2M.
REG does not have a complete income-statement cache yet.
ENTX currently screens at market cap $58.2M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ENTX and REG stock pages for the full models.
Not investment advice.